Janus kinase 3 inhibitor
Janus kinase 3 inhibitors, also called JAK3 inhibitors, are a new class of immunomodulatory agents that inhibit Janus kinase 3. They are used for the treatment of autoimmune diseases. The Janus kinases are a family of four nonreceptor tyrosine-protein kinases, JAK1, JAK2, JAK3, and TYK2. They signal via the JAK/STAT pathway, which is important in regulating the immune system. Expression of JAK3 is largely restricted to lymphocytes (predominant expression is in the hematopoietic system), while the others are ubiquitously expressed, so selective targeting of JAK3 over the other JAK isozymes is attractive as a possible treatment of autoimmune diseases.
Link from a Wikipage to another Wikipage
primaryTopic
Janus kinase 3 inhibitor
Janus kinase 3 inhibitors, also called JAK3 inhibitors, are a new class of immunomodulatory agents that inhibit Janus kinase 3. They are used for the treatment of autoimmune diseases. The Janus kinases are a family of four nonreceptor tyrosine-protein kinases, JAK1, JAK2, JAK3, and TYK2. They signal via the JAK/STAT pathway, which is important in regulating the immune system. Expression of JAK3 is largely restricted to lymphocytes (predominant expression is in the hematopoietic system), while the others are ubiquitously expressed, so selective targeting of JAK3 over the other JAK isozymes is attractive as a possible treatment of autoimmune diseases.
has abstract
Janus kinase 3 inhibitors, als ...... atment of autoimmune diseases.
@en
Wikipage page ID
55,340,810
page length (characters) of wiki page
Wikipage revision ID
1,004,413,607
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
comment
Janus kinase 3 inhibitors, als ...... atment of autoimmune diseases.
@en
label
Janus kinase 3 inhibitor
@en